Categories AlphaGraphs, Earnings, Health Care
AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by 4%.
Net loss, excluding special items, was $0.08 per share in the February quarter, compared to a loss of $0.16 per share in the corresponding period of 2024. On an unadjusted basis, net loss narrowed to $4.41 million or $0.11 per share in Q2 from $187.7 million or $4.67 per share in the prior-year quarter.
Revenues, on a reported basis, decreased 4% year-over-year to $72.0 million in the third quarter. The company expects fiscal 2025 sales to be in the range of $285 million to $288 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “Based on the quality of performance
we have seen through fiscal 2025, we are increasing our fiscal full-year guidance for all of our key metrics, including; total worldwide revenue, MedTech revenue growth, gross margin, adjusted EBITDA, and adjusted EPS.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
